Physician profile
Julia Fallon
NPI 1871097295
$2,951.40
in general payments reported to CMS, 2019-2025
19 companies · $855 in 2025
The $855 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $650 · 2022: $476 · 2023: $456 · 2024: $514 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,824.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $461.28 | 2022-2025 | Centurion, Clareon, Rocklatan |
| Regeneron Healthcare Solutions, INC. | $380.19 | 2023-2025 | Eylea Hd, Eylea |
| Carl Zeiss Meditec Cataract Technology INC. | $192.37 | 2023 | |
| Astellas Pharma US INC | $181.75 | 2024-2025 | Izervay |
| Abbvie INC. | $176.49 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $160.60 | 2024-2025 | Stellaris, Xipere |
| Johnson & Johnson Surgical Vision, INC. | $159.60 | 2022-2024 | Tecnis Simplicity |
| Alimera Sciences, INC. | $150.10 | 2022-2024 | Iluvien, Yutiq |
| Sight Sciences, INC. | $147.88 | 2021 | |
| Ivantis, INC | $146.20 | 2021 | |
| Mallinckrodt Hospital Products INC. | $133.68 | 2025 | Acthar |
| Eyepoint US, INC. | $124.99 | 2021 | |
| Ocular Therapeutix, INC. | $119.98 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $111.37 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $111.22 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $76.63 | 2025 | Iluvien, Yutiq |
| Apellis Pharmaceuticals, INC. | $65.61 | 2024-2025 | Syfovre |
| Dutch Ophthalmic, USA | $28.47 | 2024 | Eva, Combined Machine, Tissueblue |
| Sun Pharmaceutical Industries INC. | $22.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Fallon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.